SCHEMBL18871850

SCHEMBL18871850

CC(O)N1c2ccc(-c3ccc(C(=O)N4CCOCC4)cn3)cc2C(Nc2ccc(Cl)cn2)C[C@@H]1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 5/20 0.47
▸ CCL2 P13500 1/20 0.47
▸ HRH3 Q9Y5N1 9/20 0.43
▸ GABRA5 P31644 1/20 0.40
▸ GRM5 P41594 2/20 0.40
▸ CCNT1 O60563 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ BRD2 P25440 3/20 0.39
▸ BRD3 Q15059 3/20 0.39
▸ TRIM24 O15164 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ TAF1 P21675 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ EP300 Q09472 1/20 0.39
▸ BRDT Q58F21 1/20 0.39
▸ PBRM1 Q86U86 1/20 0.39
▸ TAF1L Q8IZX4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871993 0.93 BRD4 (0.47) BRD4HRH3GABRA5GRM5BRD2
SCHEMBL13724338 0.88 BRD4 (0.62) BRD4CCL2BRD2BRD3TRIM24
SCHEMBL15437363 0.80 BRD4 (0.63) BRD4CCL2BRD2BRD3TRIM24
SCHEMBL15437321 0.80 BRD4 (0.62) BRD4CCL2KDM4ERAB9ABRD2
SCHEMBL15437234 0.78 BRD4 (0.59) BRD4CCL2BRD2BRD3TRIM24
SCHEMBL15437187 0.77 BRD4 (0.60) BRD4CCL2BRD2BRD3TRIM24
SCHEMBL15437553 0.77 BRD4 (0.53) BRD4CCL2BRD2BRD3TRIM24
SCHEMBL18871853 0.76 BRD4 (0.48) BRD4CCL2HRH3BRD2BRD3
SCHEMBL13723764 0.76 BRD4 (0.48) BRD4CCL2HRH3BRD2BRD3
SCHEMBL15437401 0.74 BRD4 (0.60) BRD4CCL2BRD2BRD3TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-A1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS Glaxosmithkline LLC (US) 2017-05-17 — — EP disclosed
Send feedback